Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upjohn price increases

Executive Summary

Prices to wholesalers of the anxiolytic Xanax and hypnotic Halcion raised 7%, representing the second round of price hikes for the two benzodiazepine products this year; in February Upjohn raised prices for the two products by about 14%. In addition, Upjohn is also increasing prices for Micronase and the NSAID Ansaid by 6%. The price increases appear to be a response to flattening sales volume. In the second quarter, Upjohn reported a decline in sales of Xanax, Halcion and Micronase. Corporate sales increased only 2% in the quarter.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS016337

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel